Roberson Foundation Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2010
NCT01147653
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Roberson Foundation (funding)